The Canadian marijuana stocks we’ve discovered are the likeliest candidates to list on a major U.S. stock exchange. If successful, these Canadian cannabis companies could see even greater upside momentum.

CannTrust Holdings Inc. (TSX:TRST) –  $7.24
Cannabis

CannTrust Holdings is a licensed producer and distributor of pharmaceutical medical cannabis products. Incorporated in 2015, the Canada-based Company sells dried cannabis and oil extractions to clients with the help of healthcare practitioners. The Company’s 60,000 sq. ft. Vaughan, Ontario facility produces 3,600 kg of cannabis annually. With intentions to expand, CannTrust plans to build a 450,000-sq. ft. production facility in the Niagara region by 2019. Announcing a strategic partnership in October with Cannatrek Ltd, an Australian cannabis producer, the Company hopes to reach the Australian and Asian markets. On January 8, CannTrust announced its application to list the Company’s common shares on the NYSE.

• Market Cap: $762.9 million
• 7-Day Total Return: +10.2%
• 1-Month Total Return: -7.1 %

HEXO Corp. (TSX:HEXO) – $6.37
Cannabis

HEXO Corp. produces, markets, and sells cannabis products in Canada. Headquartered in Gatineau, Quebec, the Company has 310,000 sq. ft. of licensed facilities, and yearly production capacity of 25,000 kg of dried cannabis products. With a focus on expansion, the Company recently acquired a two million sq. ft. production space in Belleville, Ontario. Furthermore, HEXO also intends to build facilities in Greece through Qannabos, its joint venture partner, encouraging the establishment of a Eurozone distribution center. HEXO hopes to achieve its goal of 108,000 kg of dried flower production through its extensive one million sq. ft. greenhouse project, set to become operational by the end of 2018. On December 21, 2018, HEXO announced its application to list its shares on the NYSE.

• Market Cap: $1,262.4 million
• 7-Day Total Return: +35.2%
• 1-Month Total Return: -22.5 %

Organigram Holdings Inc. (TSXV:OGI) – $5.65
Cannabis

With a focus on providing patients with quality cannabis products, Organigram Holdings is a Canada-based company that produces and sells cannabis oil and dried cannabis through its subsidiaries. Since 2013 and with the help of healthcare providers, the Company strives to deliver safe and effective products, while conducting research in hopes of continuous improvement. OGI has increased its production capacity to 36,000k/year and is anticipating a production increase to 113,000kg/year by October 2019. The Company is the leader in the Atlantic provinces, surpassing Canopy Growth Corp (TSX:WEED), Aphria Inc (TSX:APHA), and Aurora Cannabis (TSX:ACB),with a market share of 24% in Prince Edward Island and Nova Scotia. There is speculation that the Company will up-list on the NYSE due to its similar market cap and investor audience as its competitors, however, this is yet to be confirmed.

• Market Cap: $732.0 million
• 7-Day Total Return: +16.7%
• 1-Month Total Return: +17.2 %